Inovio Pharmaceuticals (INO) announced positive results for phase 1/2 trial of INO-3107

Inovio Pharmaceuticals (INO) released data on its INO-3107 phase 2 trial. Positive news! 🥂Подробнее

Inovio Pharmaceuticals (INO). Akcie / InvestícieПодробнее

Inovio (INO) INO-3107 Phase 1/2 trial can be used to submit a BLA 🥂Подробнее

INOVIO Pharmaceuticals initiates phase one human clinical trial for COVID-19 vaccineПодробнее

INOVIO's Phase 2 clinical trial underwayПодробнее

Inovio (INO) reports positive phase 1b results for INO-4201 as an Ebola Booster 🥂Подробнее

Inovio Pharmaceuticals (INO)Подробнее

INOVIO PHARMACEUTICALS STOCK PHASE 1 TRIAL RESULTS!! BUY NOW?(INO)🚨BIOTECH STOCKS ANALYSIS🎯Подробнее

INOVIO begins phase 1 clinical trial for vaccineПодробнее

Vaccine Receives FDA Breakthrough Designation for Recurrent Respiratory Papillomatosis TreatmentПодробнее

Overview of Inovio Pharmaceuticals (INO) and Why I like as Long Term HoldПодробнее

Inovio PharmaceuticalsПодробнее

San Diego's Inovio working to develop universal COVID-19 vaccineПодробнее

INOVIO DNA Immunotherapy and GBMПодробнее

Top Stock to Watch Out for - Inovio Pharmaceuticals (INO)Подробнее

Inovio Coronavirus Vaccine Results Fall ShortПодробнее

Inovio Pharmaceuticals (INO) ..... A detailed Review ...Подробнее

Inovio Pharmaceuticals (INO) 3 new trials in the pipeline?Подробнее

INO Moved Down 42% TodayПодробнее